Trade Summary

3 days ago, Patel Sanj K, serving as COB, CEO at Kiniksa Pharmaceuticals International, Plc (KNSA), sold 7,278 shares at $50.01 per share, for a total transaction value of $363,973.00. Following this transaction, Patel Sanj K now holds 237,763 shares of KNSA.

This sale represents a 3.00% decrease in Patel Sanj K's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, April 6, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 8, 2026, 2 days after the trade was made.

Kiniksa Pharmaceuticals International, Plc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.